News | April 20, 2009

Sorin, Japan Lifeline Sign Exclusive Distribution Agreement for Heart Valves Portfolio


April 20, 2009 - Sorin Group entered into a long-term exclusive distribution agreement with Japan Lifeline Co. Ltd. (JLL), a distributor of medical devices in Japan, for the entire portfolio of Sorin’s Heart Valves Business Unit, including mechanical heart valves and annuloplasty rings.
JLL will also distribute Sorin’s Mitroflow tissue heart valve and the sutureless Perceval heart valve upon receipt of regulatory approvals. In June 2007 Sorin and JLL signed a similar accord whereby JLL became Sorin’s long-term partners for the distribution in Japan of cardiac rhythm management devices (implantable cardiac pacemakers and defibrillators).
For more information: www.sorin.com


Related Content

News | Heart Valve Technology

Nov. 17, 2025 — Royal Philips has introduced DeviceGuide, an AI-powered device tracking* solution that assists ...

Home November 17, 2025
Home
News | Heart Valve Technology | Cedars-Sinai Medical Center

Oct. 28, 2025 — People who underwent a minimally invasive procedure to have their heart’s aortic valve replaced had ...

Home October 29, 2025
Home
News | Heart Valve Technology

Aug. 28, 2025 — Medtronic plc has announced it received U.S. Food and Drug Administration (FDA) approval for the ...

Home August 29, 2025
Home
News | Heart Valve Technology

Aug. 18, 2025 — A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons ...

Home August 19, 2025
Home
News | Heart Valve Technology

Aug. 4, 2025 — Corcym announced that its Perceval Plus sutureless aortic heart valve was used in a first-ever robotic ...

Home August 05, 2025
Home
News | Heart Valve Technology

July 10, 2025 — On July 2, 2025, Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Determination ...

Home July 11, 2025
Home
News | Heart Valve Technology

June 27, 2025 – Foldax Inc., a leader in the development of innovative polymer heart valves, has announced compelling ...

Home June 27, 2025
Home
News | Heart Valve Technology

June 04, 2025 — HeartSciences Inc. has announced that the U.S. Food and Drug Administration has granted Breakthrough ...

Home June 12, 2025
Home
News | Heart Valve Technology

May 27, 2025 — Abbott has announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne ...

Home May 28, 2025
Home
News | Heart Valve Technology

May 2, 2025 – New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the ...

Home May 02, 2025
Home
Subscribe Now